ATE481415T1 - Verfahren zur selektion von hiv-1 subtyp c- isolaten, solche isolaten, sowie deren gene, modifikationen und ableitungen - Google Patents

Verfahren zur selektion von hiv-1 subtyp c- isolaten, solche isolaten, sowie deren gene, modifikationen und ableitungen

Info

Publication number
ATE481415T1
ATE481415T1 AT01956723T AT01956723T ATE481415T1 AT E481415 T1 ATE481415 T1 AT E481415T1 AT 01956723 T AT01956723 T AT 01956723T AT 01956723 T AT01956723 T AT 01956723T AT E481415 T1 ATE481415 T1 AT E481415T1
Authority
AT
Austria
Prior art keywords
isolates
derivations
subtype
genes
modifications
Prior art date
Application number
AT01956723T
Other languages
English (en)
Inventor
Carolyn Williamson
Ronald Swanstrom
Lynn Morris
Salim Karim
Robert Johnston
Original Assignee
Medical Res Council
Univ Cape Town
Univ North Carolina
Alphavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council, Univ Cape Town, Univ North Carolina, Alphavax Inc filed Critical Medical Res Council
Priority claimed from PCT/IB2001/001208 external-priority patent/WO2002004494A2/en
Application granted granted Critical
Publication of ATE481415T1 publication Critical patent/ATE481415T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01956723T 2000-07-07 2001-07-09 Verfahren zur selektion von hiv-1 subtyp c- isolaten, solche isolaten, sowie deren gene, modifikationen und ableitungen ATE481415T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21699500P 2000-07-07 2000-07-07
ZA200003437 2000-07-10
ZA200004924 2000-09-15
PCT/IB2001/001208 WO2002004494A2 (en) 2000-07-07 2001-07-09 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof

Publications (1)

Publication Number Publication Date
ATE481415T1 true ATE481415T1 (de) 2010-10-15

Family

ID=32511784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01956723T ATE481415T1 (de) 2000-07-07 2001-07-09 Verfahren zur selektion von hiv-1 subtyp c- isolaten, solche isolaten, sowie deren gene, modifikationen und ableitungen

Country Status (4)

Country Link
US (1) US20040116660A1 (de)
AP (1) AP2008004393A0 (de)
AT (1) ATE481415T1 (de)
DE (1) DE60143089D1 (de)

Also Published As

Publication number Publication date
US20040116660A1 (en) 2004-06-17
AP2008004393A0 (en) 2008-04-30
DE60143089D1 (de) 2010-10-28

Similar Documents

Publication Publication Date Title
DE60208373D1 (de) Polyaryleneether-polyolefinzusammensetzung, verfahren zu deren herstellung und formassen daraus
ATA10182002A (de) Diamantelektrode und verfahren zu ihrer herstellung
EP1228061A4 (de) Dipeptidyl-peptidase-iv-inhibitoren, verfahren zu deren herstellung sowie deren verwendung
DE60139055D1 (de) Material für Photo-Orientierungsschicht, Photo-Orientierungsschicht und Verfahren zu deren Herstellung
DE50011418D1 (de) Vorrichtung sowie Verfahren zum Stapeln von flächigen Gütern
DE60107450D1 (de) Verfahren zur herstellung von fluoroelastomeren
DE10192100T1 (de) Abtastkarte und Verfahren zu deren Herstellung
DE60233058D1 (de) Silsesquioxanderivate und verfahren zu ihrer herstellung
DE60131708D1 (de) Druckkopf und Verfahren zu dessen Herstellung
DE10393704D2 (de) Nancomposite, Verfahren zu ihrer Herstellung und ihre Verwendung
DE50102118D1 (de) Verfahren zur herstelling von 1,2-dichlorethan
DE60133316D1 (de) System und verfahren zum abfangen von telekommunikationen
DE60218524D1 (de) Verfahren zur herstellung von wasserlöslichen methacrylpolymeren, wasserlösliche methacrylpolymere und deren verwendung
DE60111904D1 (de) Biosensor und verfahren zu dessen herstellung
DE60108950D1 (de) Verfahren und vorrichtung zur plasmidgewinnung mit hilfe von ultrafiltration
DE60200038D1 (de) Verpackungsmaterial, Verfahren zu seiner Herstellung, sowie daraus hergestellte Verpackung
DE60030811D1 (de) Verfahren zur Ampifizierung von RNA
DE60144361D1 (de) Verfahren zur Reinigung von Vinylpolymeren
DE60120945D1 (de) System und Verfahren zum Bereitstellen von Dienstleistungen
DE60125055D1 (de) Verfahren zur zuführung von umschlägen
EP1497416A4 (de) Thermostabile dna-polymerasen und verfahren zu deren herstellung
EP1666413A4 (de) Tantalcarbid, verfahren zur herstellung von tantalcarbid, tantalcarbiddraht und tantalcarbidelektrode
ATE522205T1 (de) Testosteronhaltiges transdermales therapeutisches system und verfahren zu seiner herstellung
DE69904583D1 (de) Verbessertes verfahren zur herstellung von stahl
DE60104976D1 (de) Verfahren zur Bereitstellung von Dienstleistungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties